Clinical Trials Directory

Trials / Completed

CompletedNCT03036761

Interest of Auriculotherapy in Prophylaxis of Migraine and Headache in Patients With Migraines

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Hopital Foch · Academic / Other
Sex
Female
Age
18 Months – 80 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to show that auriculotherapy decreases the number of days with painful episodes of migraine and headache after 3 months of treatment

Detailed description

Prospective, multicenter, controlled and randomized study. At the inclusion: * initial assessment of migraine and headache attacks of the last 3 months with the migraine/headache/treatment diary; * quality of life assessment (MIDAS questionnaire). Patients are randomized in 2 groups (distribution 2/3 AUR+, 1/3 AUR-): * AUR+: experimental group "Auriculotherapy". Patients benefit from 3 sessions of auriculotherapy at one month intervals. * AUR-: control group. Patients do not benefit from auriculotherapy. After 3 months, a visit of Algology is carried out : * final assessment of migraine and headache attacks of the last 3 months with the migraine/headache/treatment diary; * quality of life assessment (MIDAS questionnaire).

Conditions

Interventions

TypeNameDescription
PROCEDUREAuriculotherapy3 sessions of auriculotherapy at one month intervals.

Timeline

Start date
2017-01-18
Primary completion
2020-12-14
Completion
2021-03-22
First posted
2017-01-30
Last updated
2021-04-21

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03036761. Inclusion in this directory is not an endorsement.